✦ LIBER ✦

P.488 Chronic hepatitis C in injecting drug users: a comparison with non-injecting drug users in the same geographic area

✍ Scribed by D.A. Price; M.L. Schmid; K. Agarwal; M. Hewett; W.L. Craig; A.D. Burt; M.F. Bassendine

Book ID: 117770696
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 143 KB
Volume: 36
Category: Article
ISSN: 1386-6532
DOI: 10.1016/s1386-6532(06)80661-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Seroprevalence of anti-hepatitis C virus

Seroprevalence of anti-hepatitis C virus (anti-HCV) antibody and HCV-related risk in injecting drug users in northern India: Comparison with non-injecting drug users

✍ Basu, Debasish; Kumar, Vineet; Sharma, Arun Kumar; Barnwal, Pawan Kumar; Mattoo, 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 153 KB

P.451 Hepatitis C virus immunovirology i

P.451 Hepatitis C virus immunovirology in a social network of injecting drug users

✍ M. Hellard; C. Aitken; M. Bharadwaj; S. Bowden 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 275 KB

Liver enzyme values in injection drug us

Liver enzyme values in injection drug users with chronic hepatitis C

✍ S.H. Mehta; D. Netski; M.S. Sulkowski; S.A. Strathdee; D. Vlahov; D.L. Thomas 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 246 KB

Once more unto the breach: controlling h

Once more unto the breach: controlling hepatitis C in injecting drug users

✍ A. Wodak; Nick Crofts 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 324 KB

The epidemic history of hepatitis C amon

The epidemic history of hepatitis C among injecting drug users in Flanders, Belgium

✍ C. Matheï; S. Van Dooren; P. Lemey; P. Van Damme; F. Buntinx; A.-M. Vandamme 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 191 KB

Prevalence of hepatitis B virus and risk

Prevalence of hepatitis B virus and risk factors in Brazilian non-injecting drug users

✍ Renata C. Ferreira; Fabiana P. Rodrigues; Sheila A. Teles; Carmen L.R. Lopes; An 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 2 views

## Abstract Non‐injecting drug users are at high‐risk for acquiring hepatitis B virus (HBV), although the factors contributing to this increased risk are not known. In the present study, the overall and occult HBV infection prevalence rates were determined in a large population of non‐injecting dru